Condition
Magnesium Sulfate Causing Adverse Effects in Therapeutic Use
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05427149Not ApplicableCompletedPrimary
The Effect of Intrathecal Magnesium Sulfate on Shivering
NCT05158647Phase 2CompletedPrimary
Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block
NCT04013243Not ApplicableCompletedPrimary
Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade
Showing all 3 trials